MedPath
HSA Approval

BEACTAFED CO SYRUP

SIN03140P

BEACTAFED CO SYRUP

BEACTAFED CO SYRUP

May 30, 1989

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

R05DA20

combinations

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE LTD

Active Ingredients

CODEINE PHOSPHATE

10 mg/5 ml

Codeine

TRIPROLIDINE HCl

1.25 mg/5 ml

Triprolidine

PSEUDOEPHEDRINE HCl

32 mg/5 ml

Pseudoephedrine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.